Valeant Pharmaceuticals International Director of Sales Salaries in Baltimore, MD
The average Valeant Pharmaceuticals International Director of Sales in Baltimore, MD earns an estimated $188,116 annually, which includes an estimated base salary of $135,330 with a $52,786 bonus. Valeant Pharmaceuticals International's Director of Sales compensation is $64,210 less than the US average for a Director of Sales. Director of Sales salaries at Valeant Pharmaceuticals International in Baltimore, MD can range from $128,000 - $248,000.
In Baltimore, MD, The Sales Department at Valeant Pharmaceuticals International earns $31,026 more on average than the Customer Support Department.
Last updated 3 years ago.
- $135,330
- avg. base
- $52,786
- avg. bonus
Director of Sales Salaries at Valeant Pharmaceuticals International
In Baltimore, MD, Directors of Sales earn $1,145 more than Directors of Sales.
Compensation at Valeant Pharmaceuticals International by Department
In Baltimore, MD, The Sales Department averages $31,026 more than the Customer Support Department, and $15,294 less than the Product Department
Director of Sales Compensation by Gender (All Companies)
The average female Director of Sales at companies similar size to Valeant Pharmaceuticals International reported making $245,429, while the average male Director of Sales at similar sized companies reported making $235,680.
Director of Sales Compensation by Ethnicity (All Companies)
The average Caucasian Director of Sales at companies similar size to Valeant Pharmaceuticals International reported making $240,787, while the average Hispanic or Latino Director of Sales at similar sized companies reported making $204,180.
How Directors of Sales at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Directors of Sales at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Directors of Sales at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
